Bharat Biotech Ends Agreements With Two Brazilian Companies Amid Controversy
Hyderabad: Drugmaker Bharat Biotech ended agreements with two Brazilian companies amid controversy over a $324 million deal.
The termination of the agreements with Precisa Medicamentos and Envixia Pharmaceuticals came after the deal set…